{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:12:49Z","timestamp":1793236369502,"version":"4.5.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>July 1, 2019, JAMA Internal Medicine released online an article authored by Kitahara et al entitled \u201cAssociation of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism.\u201d The Altmetric Attention Score, a global indicator of interest from lay public and colleagues, skyrocketed to 223 by July 7, placing the article in the top 5% of all scored reports. The overall perception of death from cancer risk associated with <jats:sup>131<\/jats:sup>I is inflated and not supported by evidence. As co-authors of this article, we offer previously unpublished data and analysis that (1) disputes clinical significance of the associated risk from <jats:sup>131<\/jats:sup>I and (2) shows, again, that antithyroid drugs carry a statistically significant and a much more obvious cancer death risk.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002792","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T06:47:26Z","timestamp":1566888446000},"page":"789-791","source":"Crossref","is-referenced-by-count":30,"title":["Spotlight on the Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism is Keeping the Highest Risk From Antithyroid Drugs in the Blind Spot"],"prefix":"10.1097","volume":"44","author":[{"given":"Mark","family":"Tulchinsky","sequence":"first","affiliation":[{"name":"Section of Nuclear Medicine, Department of Radiology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Bertrand","family":"Brill","sequence":"additional","affiliation":[{"name":"Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"key":"bib1-20230925","article-title":"Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism","year":"2019","journal-title":"JAMA Intern Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1667\/RR14160.1","article-title":"Organ dose estimates for hyperthyroid patients treated with (131)I: an update of the thyrotoxicosis follow-up study","volume":"184","year":"2015","journal-title":"Radiat Res"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.280.4.347","article-title":"Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group","volume":"280","year":"1998","journal-title":"JAMA"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jcem-38-6-976","article-title":"Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study","volume":"38","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jama.1968.03140380059014","article-title":"Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study","volume":"205","year":"1968","journal-title":"JAMA"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/oxfordjournals.aje.a114900","article-title":"Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women","volume":"127","year":"1988","journal-title":"Am J Epidemiol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ije\/11.3.218","article-title":"Cancer incidence following treatment of hyperthyroidism","volume":"11","year":"1982","journal-title":"Int J Epidemiol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A 2013 European survey of clinical practice patterns in the management of Graves' disease","volume":"84","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves' disease","volume":"97","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:01:03Z","timestamp":1695621663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002792","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,26]]}}}